Kairos Venture Partners
Venture capitalBeverly Hills · 1 people tracked
Find your way into Kairos Venture Partners
Sign up to see every warm intro you have to Kairos Venture Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kairos Venture Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Kairos Venture Partners is a venture fund manager based in Beverly Hills. SEC filings show 3 venture funds on record, most recently Kairos Venture Partners III, L.P. ($250M offering) filed December 2021.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 4 of 5 portfolio companiesBiotech ×2Healthtech ×2Advanced Manufacturing ×1AgTech ×1Medical Devices ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12018 · 12017 · 12016 · 15 dated
Rancho Santa Margarita, US
Mark Pollard(Executive Officer, Director)Kenneth Charhut(Executive Officer, Director)Nikolai Liachenko(Director)
BoardJerry Pellizzon(Director)
Board seatJames Demetriades· per SEC Form D · $2.3M raise · filed Feb 2018
Co-investorsKairos Venture Investments, Llc
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.
Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US
Frank Maguire(Executive Officer, Director)
BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)
Board seatJames Demetriades· per SEC Form D · $9M raise · filed May 2017
Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation FundBioStar CapitalBioStar VenturesSUMMATION HEALTH VENTURES
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
BiotechHaddonfield, US
Patrick T. Mooney(Executive Officer)in
BoardTodd Thomson(Director)inMichael D. Poisel(Director)Chris Arendt(Director)
Board seatJames Demetriades· per SEC Form D · $10M raise · filed Apr 2026
Co-investorsKairos Venture Investments, LlcIA Global
AgTechSanta Monica, US
Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in
BoardGANESH KISHORE(Director)inALAN BOYCE(Director)
Board seatJames T Demetriades· per SEC Form D · $40M raise · filed Apr 2026
Co-investorsAliment CapitalKairos Venture Investments, LlcLanx CapitalPontifax AgTechSpruce Capital PartnersVivo Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Kairos Venture Partners made?
- Kairos Venture Partners has 5 tracked investments, including 2 dated in the last 24 months.
- Where is Kairos Venture Partners located?
- Kairos Venture Partners is headquartered in Beverly Hills, US.












